Alternative splicing in oncogenic kinases: from physiological functions to cancer - Wikidata - wikimedia - TriplyDB

Alternative splicing in oncogenic kinases: from physiological functions to cancer

Alternative splicing in oncogenic kinases: from physiological functions to cancer

http://www.wikidata.org/entity/Q35295203

about

Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.BaxΔ2 Family Alternative Splicing Salvages Bax Microsatellite-Frameshift Mutations.Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome.Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.MET and MST1R as prognostic factors for classical Hodgkin's lymphoma.Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data

P2860

Q26773907-2150524E-F115-42CE-8B8D-F28FE499E979 Q27001635-19B86B1A-E1E4-4570-B345-F7CEFDF59D3C Q35555483-CBFCAF49-F382-4F91-BCBA-B794585C7336 Q37424404-FFD840C7-B3FB-4E67-A326-8CF6ACB069CF Q39263442-C1231ED0-62E3-4272-B678-C2361D7D6C0E Q47110708-A7C4235F-BE5D-4BB6-B099-5521556CA661 Q54439373-E903FAAC-F5B0-4444-9B4B-4EBDDCD366A7 Q58785616-53D33268-9D98-466A-B48B-D1BD69D8B758

P2860

Alternative splicing in oncogenic kinases: from physiological functions to cancer

http://www.wikidata.org/entity/Q35295203

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Alternative splicing in oncogenic kinases: from physiological functions to cancer

@ast

Alternative splicing in oncogenic kinases: from physiological functions to cancer

@en

type

label

Alternative splicing in oncogenic kinases: from physiological functions to cancer

@ast

Alternative splicing in oncogenic kinases: from physiological functions to cancer

@en

prefLabel

Alternative splicing in oncogenic kinases: from physiological functions to cancer

@ast

Alternative splicing in oncogenic kinases: from physiological functions to cancer

@en

P1433

Q35295203-E8C20F97-8201-4586-8AF1-0CDAC1E6BACE

P1476

Q35295203-A82DBD09-B303-4360-A8AA-2255C64C4D11

P2093

Q35295203-2A269F9B-C45F-4FFA-8168-45B36E465815

P2860

Q35295203-00011AE2-C35B-4313-B0C9-D220F5483DBE

Q35295203-00BB6D3F-882F-4F3F-A478-72572548DC6A

Q35295203-00EFB45B-1154-4D24-BC97-EE9B9E926D25

Q35295203-00F56712-D75D-4265-8073-8B0A403F7DB6

Q35295203-04C88E39-9E3A-45E9-A72E-A13871A059B8

Q35295203-05B586C8-F9E7-489D-A025-1D8A673CEBBE

Q35295203-08C93FDB-D4FD-416E-B897-589779918CEC

Q35295203-0C16C7D1-CD3B-4A7D-8AD9-59EAA6E95FC3

Q35295203-0C36706C-6EFA-4F96-A7B5-1AD90750E4B9

Q35295203-0FB005EF-B199-4895-A3AB-C01AA1CFF067

P304

Q35295203-6114CBBC-B83A-4375-894E-EFFE1885AE0C

P31

Q35295203-F8691064-61D8-4632-94F3-D9AEBFE1E445

P356

Q35295203-DB08B3CC-DC13-47D4-8107-A6E8CDAC9557

P478

Q35295203-3540A9E4-F138-489B-987F-22B34145E8F8

P50

Q35295203-428250EE-66E5-4EFC-9A02-AB69F75262C9

Q35295203-B227972B-9FA3-48A7-8C21-03E3DB3DB300

P577

Q35295203-13DE4D50-3CF3-4E48-8C75-C6AF8D901361

P5875

Q35295203-F103E1C1-B9A5-4949-B04F-273E77FFEEE4

P698

Q35295203-74A7DD5D-8981-4915-99A9-2FD0399CC958

P932

Q35295203-79FB688F-A4F7-40A3-A11D-822AEDCB0A6A

P356

P1433

Journal of Nucleic Acids

P1476

Alternative splicing in oncogenic kinases: from physiological functions to cancer

@en

P2093

Coralie Dorard

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase

Cellular signaling by fibroblast growth factor receptors

The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain

Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

The protein kinase complement of the human genome

Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy

A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype

Differential regulation of B-raf isoforms by phosphorylation and autoinhibitory mechanisms

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

P304

639062

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/639062

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

Sabine Druillennec

P577

2011-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51721694

http://www.w3.org/2001/XMLSchema#string

P698

22007291

http://www.w3.org/2001/XMLSchema#string

P932

3189609

http://www.w3.org/2001/XMLSchema#string